Clinical Trials Logo

Clinical Trial Summary

This study is a single-arm, 12-week trial to test the feasibility of a PP-MI intervention for patients recently admitted following ACS. PP-MI is a novel positive psychology-based health behavior intervention that is adapted for patients hospitalized for ACS. The intervention aims to cultivate positive emotions in this vulnerable population that could provide broad and significant health benefits, and may have distinct-and more powerful-effects than simply attempting to dampen negative emotions. The primary aim is to assess whether the intervention exercises are feasible and linked with immediate boosts in positive affect upon completion. The secondary goal is to provide the research team with greater experience recruiting inpatients with an ACS, successfully completing intervention sessions, and administering psychological and medical assessments by phone.


Clinical Trial Description

The initial study visit will occur in-person two weeks after discharge from the hospital. Participants will meet with a member of the study staff (the study "trainer") and complete self-report questionnaires assessing health behavior adherence and mental and physical health. Then, a study interventionist will provide a treatment manual for the positive psychology + motivational interviewing intervention, review the rationale for the initial exercise, and assign the first exercise. If the participant is in the positive psychology + motivational interviewing condition, the trainer will explain the rationale for both the positive psychology and goal-setting and motivational interviewing portions of the program, and will be assigned the first exercise. Participants will then be given an accelerometer, which they will be asked to wear for 7 days to ensure that they are comfortable with the device and that useable data can be obtained from the participant. Participants will then complete twelve 30-minute weekly phone sessions with a study trainer. The phone sessions primarily will include a review of the prior week's session content and a discussion of the rationale and assignment of the next week's exercise/assignment. Upon the completion of these calls, a blinded member of the study staff will call participants to administer self-report outcome measures. Participants will also be asked to wear an accelerometer at the follow-up timepoint as an objective measure of physical activity, which they will return by mail to the study staff. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04062383
Study type Interventional
Source Northwestern University
Contact
Status Terminated
Phase N/A
Start date February 24, 2020
Completion date March 13, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03273075 - Add-on Cangrelor in STEMI-triggered Cardiac Arrest Phase 4
Completed NCT03103620 - Safety and Effectiveness Evaluation of COBRA PzF Coronary Stent System: A Post Marketing Observational Registry
Recruiting NCT04222608 - The BRAvAdO Registry
Recruiting NCT06095557 - MCG Discovery Study in Emergency Departments N/A
Completed NCT04000490 - External Validation of the SCARE Score
Recruiting NCT04140019 - Early Cardiac Magnetic Resonance Imaging in Suspected Non-ST-Elevation Myocardial Infarction
Completed NCT04485754 - Telemedicine Follow-up for Post-ACS Patients N/A
Completed NCT03122184 - Positive Psychology for Acute Coronary Syndrome Patients N/A
Completed NCT03138473 - Impact of Residual Syntax Score and Syntax Revascularization Index on Outcomes of ACS Patients With Multi-Vessel Disease
Completed NCT04219761 - National Tunisian Registry of Percutaneous Coronary Intervention
Recruiting NCT03707496 - A Registry of De Winter Symdrome of Single Center
Recruiting NCT05378321 - Prevalence of NAFLD in ACS Patients N/A
Recruiting NCT03413410 - A Multi-Center Study on the Metoprolol Optimal Dosing Pathway of Metoprolol Application in Chinese Patients With Acute Coronary Syndrome N/A
Completed NCT03793582 - Impact of OSA on Outcomes in Acute Coronary Syndrome
Terminated NCT05323136 - Evaluate the Effects of Renal Impairment on the Pharmacokinetics and Pharmacodynamics Phase 1
Recruiting NCT06283888 - CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention Phase 4